Insights on Clinical Trials
-
Adapting Clinical Supply Strategies Through The Phases
5/17/2024
Phase-appropriate logistics are essential to manage resources efficiently, maintain regulatory compliance, and ensure timely delivery.
-
The Stakeholder Benefits Of EHR eSource In Clinical Trials
5/15/2024
Discover the transformative power of EHR eSource integration through the eyes of a clinical research coordinator and project director in an adaptive platform trial.
-
Eight Ways Medical Device Clinical Trials Differ From Drug Trials
5/15/2024
Delve into the nuanced disparities between medical device and drug clinical trials with eight critical differentiators shaping regulatory pathways and patient safety.
-
Is A One-Time Cure for HIV on the Horizon?
5/14/2024
Addimmune's CMO, Dr. Marcus Conant, shares information about the company's lead asset, AGT103-T, which has been designed to provide a functional cure for HIV.
-
Navigating CGT Commercialization: Key Areas For Success
5/13/2024
The cutting-edge realm of cell and gene therapy holds immense promise for revolutionizing healthcare, and its successful commercialization hinges on several key factors.
-
Treating Alzheimer's With NK Cell Therapy
5/8/2024
I met with NKGen Biotech's CEO, Dr. Paul Song, MD, to learn how a serendipitous discovery shifted the company's clinical focus from cancer to Alzheimer's disease.
-
Shifting The Approach: 4 Strategies For ICH E6(R3) Implementation
4/30/2024
In addition to codifying some best practices, R3 suggests sponsors take a proportionate approach to identifying and managing areas of risk.
-
Cell & Gene: The Podcast Post-Episode Recap: BlueRock Therapeutics’ Dr. Ahmed Enayetallah
4/30/2024
This article shares highlights from Cell & Gene: The Podcast featuring BlueRock Therapeutics’ Dr. Ahmed Enayetallah. Heshares impressive data from the Phase 1 study to treat Parkinson's disease.
-
Cell & Gene: The Podcast Post-Episode Recap: Vor Bio’s Dr. Robert Ang
4/26/2024
Welcome to my new article series, Cell & Gene: The Podcast Post-Episode Recap, which shares highlights, quotes, and more from recently aired episodes of Cell & Gene: The Podcast.
-
Advantages Of Cas9 mRNA For Gene Editing
4/26/2024
Discover why Cas9 mRNA is the preferred choice for precise gene editing, offering efficient delivery, transient expression, and flexible targeting.